Similar articles

• Inhibition of orotate phosphoribosyltransferase and orotidine-5'-phosphate decarboxylase of human erythrocytes by purine and pyrimidine nucleotides.

  Tax WJ, Veerkamp JH. Tax WJ, et al. Biochem Pharmacol. 1979 Mar 15;28(6):829-31. doi: 10.1016/0006-2952(79)90365-4. Biochem Pharmacol. 1979. PMID: 454480 No abstract available.
• Alteration of quaternary structural behaviour of an hepatic orotate phosphoribosyltransferase-orotidine-5'-phosphate decarboxylase complex in rats following allopurinol therapy.

  Brown GK, Fox RM, O'Sullivan WJ. Brown GK, et al. Biochem Pharmacol. 1972 Sep 15;21(18):2469-77. doi: 10.1016/0006-2952(72)90418-2. Biochem Pharmacol. 1972. PMID: 4646793 No abstract available.
• Allopurinol and enzymes of de novo pyrimidine biosynthesis.

  Foster DM, Lee CS, O'Sullivan WJ. Foster DM, et al. Biochem Med. 1973 Feb;7(1):61-7. doi: 10.1016/0006-2944(73)90099-9. Biochem Med. 1973. PMID: 4684088 No abstract available.
• Inhibitors of orotate phosphoribosyl-transferase and orotidine-5'-phosphate decarboxylase from mouse Ehrlich ascites cells: a procedure for analyzing the inhibition of a multi-enzyme complex.

  Traut TW, Jones ME. Traut TW, et al. Biochem Pharmacol. 1977 Dec 1;26(23):2291-6. doi: 10.1016/0006-2952(77)90293-3. Biochem Pharmacol. 1977. PMID: 563234 No abstract available.
• Effect of allopurinol and its metabolic derivatives on the configuration of human orotate phosphoribosyltransferase and orotidine 5'-phosphate decarboxylase.

  Grobner W, Kelley WN. Grobner W, et al. Biochem Pharmacol. 1975 Feb 1;24(3):379-84. doi: 10.1016/0006-2952(75)90221-x. Biochem Pharmacol. 1975. PMID: 1125044 No abstract available.